 |
|
|
|
 |
|
|
|
| Article 1 to 10 out of 1213
|
|
-
Intercell AG to acquire Iomai Corporation to expand late stage product pipeline and strengthen leadership in vaccine innovation
(14 May 2008)
Intercell AG and Iomai Corporation announced that they have entered into a definitive agreement pursuant to which Intercell will acquire Iomai for USD 6.60 per share representing a fully diluted equity value of approximately USD 189 million ......
-
Quest PharmaTech Signs Agreement to sell Bionex Technology
(13 May 2008)
Quest PharmaTech Inc. announced that it has signed a Technology Transfer Agreement with Peking Marvel Cleansing Supplies Co., Ltd., a China-based company, to sell its interest in the Bionex Technology. Peking Marvel is anticipated to be ......
-
Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics
(09 May 2008)
Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing
Microbix Biosystems Inc. announced that it intends to spin off its Urokinase assets into a new private company, Klarogen Biotherapeutics Inc., which would become the sole commercial-scale manufacturer and supplier of the clot-busting drug after ......
-
Cytochroma opens U.S. headquarters in Illinois
(05 May 2008)
Cytochroma announced the opening of its U.S. headquarters in Bannockburn, Illinois, located in the greater Chicago area. The site will serve as the Company's base for U.S. commercial activities and for the expansion of its North American ......
-
Dyax Corp. Announces Intent to Close Belgium Research Facility
(30 Apr 2008)
Dyax Corp. announced that the Board of Directors of its Belgian subsidiary, Dyax SA, has initiated discussions with its 24 employees as it considers a possible closure of the Liege-based research facility. The closure option would allow for ......
-
DSM acquires PTG to expand its fast growing biomedical materials business
(30 Apr 2008)
Royal DSM N.V. announced an agreement to acquire The Polymer Technology Group, Inc. (PTG) of Berkeley (California, United States). Through the acquisition of privately-held PTG, DSM oimproves its position in the field of biomedical polymers, ......
-
GE Healthcare completes acquisition of Whatman plc
(29 Apr 2008)
GE Healthcare, a unit of General Electric Company announced that it has completed the acquisition of Whatman plc, a global supplier of filtration products and technologies. The acquisition expands GE Healthcare's offering for life science ......
-
Solvay Pharmaceuticals S.A. launches friendly bid to acquire Innogenetics
(29 Apr 2008)
Building on a successful R&D co-operation
Solvay Pharmaceuticals S.A., a subsidiary of Solvay, and Innogenetics N.V. jointly announced that Solvay Pharmaceuticals S.A. will make a conditional tender offer to acquire Innogenetics in a cash transaction valued at EUR 5.75 per share. ......
-
MedMira Continues Momentum in Eastern Europe Expanding Distribution Network to Include Moldova and Ukraine
(29 Apr 2008)
Regional Distributor Enters New Markets with MiraCare and Multiplo Tests
MedMira Inc. announced that it continues to build sales momentum, expand into new sales territories, and extend its product reach in Eastern Europe. Building on an initial distribution channel in Romania MedMira is expanding its footprint in ......
-
Navamedic sells chitin operation - Focus on core strategy
(25 Apr 2008)
Navamedic sells ChitiNor AS to Seagarden AS for NOK 2.3 million in shares. The decision is in line with the company's strategy to move from a glucosamine pure-play to a specialty pharma company with a broad product portfolio. While the sale ......
|
|
|
Top